Cargando…

Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm

Biliary tract cancers (BTCs) are a heterogeneous group of adenocarcinomas that originate from the epithelial lining of the biliary tree. BTCs are characterized by presentation with advanced disease precluding curative surgery, rising global incidence, and a poor prognosis. Chemotherapy is the mainst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakrabarti, Sakti, Kamgar, Mandana, Mahipal, Amit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465131/ https://www.ncbi.nlm.nih.gov/pubmed/32722188 http://dx.doi.org/10.3390/cancers12082039

Ejemplares similares

Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and Opportunities
por: Chakrabarti, Sakti, et al.
Publicado: (2022)

Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions
por: Chakrabarti, Sakti, et al.
Publicado: (2020)

Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)—Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC)
por: Chakrabarti, Sakti, et al.
Publicado: (2022)

Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers
por: Kang, Sandra, et al.
Publicado: (2022)

Research Progress of Biliary Tract Cancers
por: Fonkoua, Lionel Aurelien A. Kankeu, et al.
Publicado: (2021)

The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review
por: Chakrabarti, Sakti, et al.
Publicado: (2020)

A Patient With Locally Advanced Mismatch-Repair-Deficient Pancreatic Ductal Adenocarcinoma Successfully Treated With Neoadjuvant Immunotherapy
por: Cox, Ronald E, et al.
Publicado: (2021)

Targeted Therapy for Biliary Tract Cancer
por: Furuse, Junji, et al.
Publicado: (2011)

The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer
por: Gkika, Eleni, et al.
Publicado: (2020)

Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma
por: Tella, Sri Harsha, et al.
Publicado: (2023)

Combination Therapies for Advanced Biliary Tract Cancer
por: Zeng, Weifeng, et al.
Publicado: (2023)

Immunotherapy and Targeted Therapy for Advanced Biliary Tract Cancer: Adding New Flavors to the Pizza
por: Queiroz, Marcello Moro, et al.
Publicado: (2023)

Evolving Paradigms in Melanoma Therapy
por: Olszanski, Anthony J., et al.
Publicado: (2016)

Immunotherapy in Advanced Biliary Tract Cancers
por: Boilève, Alice, et al.
Publicado: (2021)

Targeted Therapies in Advanced Cholangiocarcinoma
por: Storandt, Michael H., et al.
Publicado: (2023)

Targeted Therapy in Biliary Tract Cancers
por: Merla, Amartej, et al.
Publicado: (2015)

Promising Molecular Targets for the Targeted Therapy of Biliary Tract Cancers: An Overview
por: Yang, Wenwei, et al.
Publicado: (2021)

Chemotherapy and targeted therapy for advanced biliary tract cancers: an umbrella review
por: Wang, Yaoqun, et al.
Publicado: (2023)

Targeted therapies in advanced biliary tract cancers—a narrative review
por: LaPelusa, Michael, et al.
Publicado: (2023)

Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms
por: El-Amm, Joelle, et al.
Publicado: (2013)

Evolving Paradigms in the Management of Multiple Myeloma: Novel Agents and Targeted Therapies
por: Larsen, Jeremy T., et al.
Publicado: (2015)

Adjuvant therapy of biliary tract cancers
por: Kefas, Joanna, et al.
Publicado: (2023)

Paradigm shift of chemotherapy and systemic treatment for biliary tract cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib
por: Yu, James, et al.
Publicado: (2021)

Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges
por: Rizzo, Alessandro, et al.
Publicado: (2020)

Current options and future directions of systemic therapy for advanced biliary tract cancer
por: Prete, Maria Giuseppina, et al.
Publicado: (2021)

Precision Oncology Targets in Biliary Tract Cancer
por: Farha, Nicole, et al.
Publicado: (2023)

mTOR Inhibitors in Advanced Biliary Tract Cancers
por: Wu, Chao-En, et al.
Publicado: (2019)

Evolving Paradigms in the Systemic Treatment of Advanced Gallbladder Cancer: Updates in Year 2022
por: Hu, Zishuo Ian, et al.
Publicado: (2022)

A glimpse into the future of esophageal carcinoma in the United States: predicting the future incidence until 2040 based on the current epidemiological data
por: Tella, Sri Harsha, et al.
Publicado: (2023)

Immunotherapy in endometrial cancer - an evolving therapeutic paradigm
por: Longoria, Teresa C., et al.
Publicado: (2015)

The evolving treatment paradigm in myelofibrosis
por: Mesa, Ruben A.
Publicado: (2013)

Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine
por: Malenica, Ines, et al.
Publicado: (2020)

The evolving treatment paradigm of locally advanced rectal cancer: a narrative review
por: Awawda, Muhammad, et al.
Publicado: (2022)

Targeting Angiogenesis in Biliary Tract Cancers: An Open Option
por: Simone, Valeria, et al.
Publicado: (2017)

Toripalimab in advanced biliary tract cancer
por: Li, Wei, et al.
Publicado: (2022)

Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm
por: Yang, Charlie, et al.
Publicado: (2023)

Current status of chemotherapy for the treatment of advanced biliary tract cancer
por: Sasaki, Takashi, et al.
Publicado: (2013)

Quality of Life and Symptom Management in Advanced Biliary Tract Cancers
por: Hunter, Lindsay A., et al.
Publicado: (2021)

Advances in the systemic treatment of therapeutic approaches in biliary tract cancer
por: Mirallas, O., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1tagch5cejkcai6ub168dkbsec